XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.bigmoleculewatch.com/2017/06/30/update-on-amgens-pi-motion-in-amgen-v-hospira/20%Monthly2018-01-08 21:42
https://www.bigmoleculewatch.com/2017/06/30/sandoz-requests-remand/20%Monthly2018-01-08 21:43
https://www.bigmoleculewatch.com/2017/06/29/fda-accepts-celltrionteva-bla-for-biosimilar-of-rituxan/20%Monthly2018-01-08 21:45
https://www.bigmoleculewatch.com/2017/06/28/fda-seeks-comments-bla-review/20%Monthly2017-06-30 15:17
https://www.bigmoleculewatch.com/2017/06/27/interchangeable-biosimilars-expected-in-u-s-within-two-years/20%Monthly2017-06-27 16:00
https://www.bigmoleculewatch.com/2017/06/26/goodwin-webinar-reminder-the-supreme-courts-decision-in-sandoz-v-amgen/20%Monthly2018-07-24 14:10
https://www.bigmoleculewatch.com/2017/06/26/cipla-plans-to-reduce-biosimilars-investment-to-focus-on-respiratory-products/20%Monthly2018-01-08 21:49
https://www.bigmoleculewatch.com/2017/06/23/ema-committee-issues-positive-opinion-for-biogens-adalimumab-biosimilar-candidate/20%Monthly2018-01-08 21:50
https://www.bigmoleculewatch.com/2017/06/23/pfizer-gets-second-crl-on-proposed-epoetin-alfa-biosimilar/20%Monthly2018-01-08 21:51
https://www.bigmoleculewatch.com/2017/06/22/rituximab-biosimilar-approved-in-latin-america/20%Monthly2018-01-08 21:53
https://www.bigmoleculewatch.com/2017/06/22/joint-venture-to-open-biosimilar-lab-in-brazil/20%Monthly2018-01-08 21:55
https://www.bigmoleculewatch.com/2017/06/21/status-regarding-dupixent-litigations/20%Monthly2018-01-08 21:58
https://www.bigmoleculewatch.com/2017/06/21/litigation-update-amgen-v-hospira/20%Monthly2018-07-25 15:47
https://www.bigmoleculewatch.com/2017/06/20/status-update-on-janssen-v-celltrion/20%Monthly2018-07-25 15:48
https://www.bigmoleculewatch.com/2017/06/20/in-amgen-v-hospira-amgen-seeks-to-amend-its-pi-motion-in-light-of-sandoz-v-amgen/20%Monthly2018-07-25 15:48
https://www.bigmoleculewatch.com/2017/06/19/nebraska-enacts-law-to-allow-automatic-substitution-of-interchangeable-biosimilars/20%Monthly2017-06-23 14:38
https://www.bigmoleculewatch.com/2017/06/19/european-commission-approves-sandozs-rixathon-rituximab/20%Monthly2018-01-08 22:04
https://www.bigmoleculewatch.com/2017/06/16/goodwin-webinar-the-supreme-courts-decision-in-sandoz-v-amgen/20%Monthly2018-06-04 14:23
https://www.bigmoleculewatch.com/2017/06/15/adalimumab-biosimilar-demonstrates-non-inferiority-for-efficacy-and-safety/20%Monthly2018-10-10 17:23
https://www.bigmoleculewatch.com/2017/06/14/boehringer-ingelheim-announces-interim-results-on-adalimumab-biosimilar-candidate-bi695501/20%Monthly2018-01-08 22:22
https://www.bigmoleculewatch.com/2017/06/14/new-data-supports-efficacy-and-safety-of-celltrions-rituximab-biosimilar/20%Monthly2018-01-08 22:23
https://www.bigmoleculewatch.com/2017/06/13/bristol-myers-squibb-announces-new-pediatric-subcutaneous-administration-option-for-orencia-abatacept/20%Monthly2018-01-09 14:04
https://www.bigmoleculewatch.com/2017/06/13/ptab-finds-two-abbvie-adalimumab-method-of-use-patents-unpatentable-in-final-written-decisions/20%Monthly2018-01-09 14:05
https://www.bigmoleculewatch.com/2017/06/12/breaking-news-scotus-to-consider-whether-aia-review-is-constitutional/20%Monthly2017-06-16 14:33
https://www.bigmoleculewatch.com/2017/06/12/breaking-news-u-s-supreme-court-issues-decision-in-sandoz-v-amgen/20%Monthly2018-07-25 15:51
https://www.bigmoleculewatch.com/2017/06/12/coherus-receives-fdas-complete-response-letter-for-its-pegfilgrastim-biosimilar/20%Monthly2018-01-09 14:10
https://www.bigmoleculewatch.com/2017/06/09/mylan-files-two-petitions-for-ipr-of-sanofis-insulin-glargine-patents/20%Monthly2018-05-25 18:51
https://www.bigmoleculewatch.com/2017/06/08/provisional-decision-in-uk-drug-pricing-investigation-of-merck-sharp-dohme/20%Monthly2018-01-09 14:12
https://www.bigmoleculewatch.com/2017/06/08/goodwin-webinar-tc-heartlands-impact-on-hatch-waxman/20%Monthly2018-07-24 14:11
https://www.bigmoleculewatch.com/2017/06/07/biosimilar-development-updates-infliximab-ranibizumab-etanercept-filgrastim-trastuzumab/20%Monthly2018-07-24 14:12
https://www.bigmoleculewatch.com/2017/06/06/fda-advisory-committee-to-hold-public-meetings-on-amgens-proposed-bevacizumab-biosimilar-and-mylans-proposed-trastuzumab-biosimilar/20%Monthly2018-01-09 14:23
https://www.bigmoleculewatch.com/2017/06/06/ema-accepts-adalimumab-biosimilar-applications-from-fujifilm-kyowa-kirin-and-sandoz-and-an-infliximab-biosimilar-application-from-sandoz/20%Monthly2018-10-10 17:23
https://www.bigmoleculewatch.com/2017/06/05/janssen-files-new-complaint-against-celltrion-re-infliximab/20%Monthly2018-05-25 18:51
https://www.bigmoleculewatch.com/2017/06/05/abbvies-response-regarding-amgens-third-party-patent-dance-discovery-request/20%Monthly2018-01-09 14:46
https://www.bigmoleculewatch.com/2017/06/01/pfizer-files-two-ipr-petitions-on-genentechs-patent-directed-to-methods-of-making-humanized-antibodies/20%Monthly2018-07-24 14:13
https://www.bigmoleculewatch.com/2017/06/01/ema-releases-informational-guide-on-biosimilars-for-healthcare-providers/20%Monthly2017-06-02 14:01
https://www.bigmoleculewatch.com/2017/06/01/big-molecule-watch-editor-rob-cerwinski-to-speak-at-aci-annual-biosimilars-summit/20%Monthly2017-06-01 19:02